Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: A hypothesis

Clinics

Volumn 65, Issue 5, 2010, Pages 547-554

  Pereira Jr , Jose Carlos ^a   Pradella Hallinan, Marcia ^b   Pessoa, Hugo de Lins ^a  

^a FACULDADE DE MEDICINA DE JUNDIAÍ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CYP450; Dopamine; Restless Legs Syndrome; RLS; RLS pathophysiology; TSH

Indexed keywords

CYTOCHROME P 450 CYP121; CYTOCHROME P-450 CYP121; CYTOCHROME P450; DOPAMINE RECEPTOR STIMULATING AGENT; IRON; THYROID HORMONE; THYROTROPIN; TYROSINE 3 MONOOXYGENASE;

AROUSAL; CIRCADIAN RHYTHM; FEMALE; HUMAN; HYPERTHYROIDISM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RESTLESS LEGS SYNDROME; REVIEW; SLEEP DISORDER;

AROUSAL; CIRCADIAN RHYTHM; CYTOCHROME P-450 ENZYME SYSTEM; DOPAMINE AGONISTS; FEMALE; HUMANS; HYPERTHYROIDISM; IRON; PREGNANCY; PREGNANCY COMPLICATIONS; RESTLESS LEGS SYNDROME; SLEEP DISORDERS; THYROID HORMONES; THYROTROPIN; TYROSINE 3-MONOOXYGENASE;

EID: 77954361432     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000500013     Document Type: Review

References (54)

1. American Academy of Sleep Medicine. International classification of sleep disorders, sec. edition. Diagnostic and coding manual. Wetchester, Illinois: American Academy of Sleep Medicine, 2005.
2. Allen R, Picchietti D, Hening W, Tremkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101-19.
3. Lee Chiong TL, Sateia M, Carskadon M, Eds. Sleep Medicine. Philadelphia, PA: Hanley&Belfus (Elsevier), 2002.
4. Picchietti D, Allen RP, Walters AS, Davidson JE, Myers A, Ferini-Strambi L. Restless legs syndrome: prevalence and impact in children and adolescents. The Peds Rest Study. Sleep. 2006;29:29-70.
5. Earley C. Clinical practice. Restlesslegs syndrome. N Engl J Med. 2003;348:2103-9.
6. Ekbon K. Restless legs: a clinical study. Acta Med Scand. 1945;158:1-122.
7. Walters AS. Group organizer and Correpondent International Restless Legs Syndrome Study Group. Towards a better definition of the restless legs syndrome. Mov Disord. 1995;10:634-42.
8. St O' Keeffe, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23:200-03.
9. J Krieger, C Schroeder. Iron status and restless legs syndrome. Sleep Medicine Reviews. 2001;5:277-86.
10. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome. Sleep Med 2004;4:385-91.
11. Huebers HA. Non hematological manifestations of iron deficiency. In Bo Lonnerdal, editor, Iron Metabolism in Infants, CRC Press, 1990;pgs 63-72.
12. Dallman PR, Goodman Jr. The effects of iron deficiency on the hepatocyte. A biochemical and ultrastructural study. JCB. 1971;48:79-90.
13. Cupp MJ, Tracy TS. Cytochrome P450: New nomenclature and Clinical Implications. American Family Physician. 1998;57:117-26.
14. Feek CM, Sawers JSA, Brown NS, Seth J, Irvine WJ, Toft AD. Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion: evidence for an additional feedback mechanism in the control of thyroid hormone secretion. J Clin Endocrinol Metabol. 1980;51:585-9.
15. Scanlon MF, Weetman AP, Lewis M, Pourmand M, Rodrigues A, Weightman DR. Dopaminergic modulation of circadian thyrotropin rhythm and thyroid hormone levels in euthyroid subjects. J Clin Endocrinol Metabol. 1980;51:1251-6.
16. G Delitala. Dopamine and TSH secretion in man. The Lancet. 1977;310:760-1.
17. Wojcikowski J, Gocen Biowska K, Wladystawa AD. Regulation of liver cythocrome P450 by activation of brain dopaminergic system. Biochem Pharmacol. 2008;76:258-67.
18. Meyer RP, Gehlhaus M, Knoth R, Volk B. Expression and function of cytochrome p450 in brain drug metabolism. Curr Drug Metab. 2007;8:297-306.
19. Brabant G, Prank K, Ranft U, Schuermeyer TOF, Wagner H, Hauser B, et al. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J Clin Endocrinol Metab. 1990;70:403-9.
20. P. Lavie. Sleep-Wake as a biological rhythm. Annual Review of Psychology. 2001; pg277.
21. Guyton AC.Textbook of Medical Physiology. 7th Ed. W.B. Saunders Company, 1981.
22. Farwell AP, Braverman LE. Thyroid and Antithyroid Drugs. In Hardman JG, Limbird LE, Gilman AG, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Tenth edition. McGraw-Hill, New York, 2001;1563-96.
23. Parker DC, Rossman LG, Pekary AE, et AL. Effect of 64-hour sleep deprivation on the circadian waveform of thyrotropin (TSH): further evidence of sleep-related inhibition of TSH release. J Clin Endocrinol Metab. 1987;64:157-61.
24. Pannain S, Van Cauter E. Modulation of Endocrine Function by Sleep-Wake Homeostasis and Circadian Rhythmicity. Sleep Medicine Clinics. 2007;2:147-59.
25. Goichot B, Branderberg G, Saini J, Wittersheim G, and Follenius M. Nocturnal plasma thyrotropin variations are related to slow-wave sleep. J Sleep Res. 1992; 1:186-90.
26. Gronfier C, Luthringer R, Follenius M, Schaltembrand N, Macher JP, Muzet A, et al. Temporal link between plasma thyrotropin levels and electroencephalographic activity in man. Neurosci Lett. 1995;200:97-100.
27. Kaptein EM, Spencer CA, Kamiel MB, and Nicoloff JT. Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J. Clin Endocrinol Metab. 1980;51:387-393.
28. Van den Berghe G, de Zeghert F, Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol.1994;41:731-7.
29. Debayeve YA, Van den Berghe GH. Is there still a place for dopamine in the modern intensive care unit? Anesth Analg. 2004;98:461-8.
30. Shupnik MA, Greenspan SL, Ridgway EC. Transcriptional regulation of thyrotropin subunit by thyrotropin-releasing hormone and dopamine in pituitary cell culture. J. Biol. Chem 1986;261:675-9.
31. Akpinar S. Restless legs syndrome treatment with dopaminergic drugs. Clin Neuropharmacol. 1987;10:69-79.
32. Walters AS, Ondo WG, Dreykluft T, GrunsteinR, Lee D, Sethi K. Ropinirole is effective in the treatment of restless legs syndrome: TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19:1414-23.
33. Walters A, Hening W, Kavey N, Chokroverty S, Sidro-Frank S. A Double-blinded randomized cross-over trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol. 1988;24:455-8.
34. Scanlon MF, Weightman DR, Shale DJ, Mora B, Heath M, Snow MH, et al. Dopamine is a physiological regulator of Thyrotropin (TSH) in normal man. Clin Endocrinol. 1978;10:7-15.
35. Filippi L, Pezzati M, Cecchi A, Poggi C. Dopamine infusion: A possible cause of undiagnosed congenital hypothyroidism in preterm infants. Pediat Crit Care Med. 2006;7:249-51.
36. Zhang GF, Tang YL, Smith AK, Zheng-gi L, Sheng LX, Yong C, et al. Alterations in pituitary-thyroid axis function among opioids-dependent subjects after acute and protracted abstinence. Addiction biology. 2009;14:310-4.
37. Ruzsas C, Mess B. Opioidergic regulation of thyroid activity: possible interference with the serotoninergic system. Psychoneuroendocrinology. 1983;8:89-94.
38. McNamara JO. Drugs effective in the therapy of the epilepsies. In Hardman JG, Limbird LE, Gilman AG, editors, The Pharmacological Basis of Therapeutics, tenth edition, 2001. McGraw-Hill, New York.
39. Indiana University Division of Clinical Pharmacology. Cytochrome P450 Drugs Interaction Table. Version. 5;2009.
40. Glinoer D. The regulation of thyroid function in pregnancy: Pathway of endocrine adaptation from physiology to pathology. Endocrine Reviews. 1997;18:404-33.
41. Dzaja A, Wehrle R, lancel M, Pollmacher T. Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep. 2009;32:169-74.
42. Sanger N, Stahlberg S, Manthey T, Mittman K, Mellinger U, Lange E, et al. Effects of an oral contraceptive containing 30 mcg ethynil estradiol and 2 mg dienogest on thyroid hormones and androgens parameters: conventional VS. extended cycle use. Contraception. 2008;77:420-5.
43. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther. 1993;57:237-57.
44. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17 beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003;144:382-98.
45. Tan EK, Ho SC, Koh L, Pavanni R. An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation. Mov Disord. 2004;19:1365-7.
46. Tan EK, Ho SC, Eng P, Loh L, Koh L, Lum S, et al. Restless legs symptoms in thyroid disorders. Parkinsonism and Related Disorders. 2004;10:149-51.
47. Schuppert F, Diegelmann B, Geest T, Wagner TO, von-zur Muhlen A. Loss of variability in Graves' disease stimulatory TSH-receptors antibodies bind to the TSH-receptor in a continued non pulsatile and non-chaotic fashion. Chronobiologia. 1994;21:21-32.
48. Strawn JR, Ekhator NN, D'Souza BB, Geracioti TD, Geracioti JR. Pituitary-thyroid state correlates with central dopaminergic and serotoninergic activity in healthy humans. Neuropsychobiology. 2004;49:84-7.
49. Rang HP, Dale MM, Ritter JM, Flower RJ. Rang and Dale's Pharmacology, 6th edition, 2008. Elsevier, USA.
50. Greenspan SL, Resnick NM. Geriatric Endocrinology in Greenspan'S Basic & Clinical Endocrinology. Gardner DG and Shoback D, editors. McGraw-Hill, 2007, 8th edition. Pgs 844-67.
51. Walter AS. Is there a subpopulation of children with growing pains who really have restless legs syndrome? A review of the literature. Sleep Med. 2002b;3:93-8.
52. Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov. Disord. 2000;15:154-8.
53. Rye DB, Freeman AAH. Dopamine in Behavioral State Control, in Monti JM, Pandi-Perumal SR, and Sinton CM, editors: Neurochemistry of Sleep and Wakefulness. Cambridge University Press, Cambridge, 2008. Pgs 179-223.
54. Nicola S, Surmeir J, Malemka R. Dopaminergic modulation of neuronal excitability in the striatum and nucleus acumbens. A. Rev. Neurosci. 2000;23:185-215.